OCA
MREO

Octagon Capital Advisors’s Mereo BioPharma MREO Stock Holding History

Octagon Capital Advisors’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,000,000
Closed -$750K – 39
2022
Q4 		$750K Hold
1,000,000
– – 0.12% 30
2022
Q3 		$861K Hold
1,000,000
– – 0.15% 32
2022
Q2 		$1.12M Buy
+1,000,000
New +$1.12M 0.3% 19